Athina Giannoudis

3.5k total citations · 1 hit paper
50 papers, 2.7k citations indexed

About

Athina Giannoudis is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Athina Giannoudis has authored 50 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Hematology and 12 papers in Molecular Biology. Recurrent topics in Athina Giannoudis's work include Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Cervical Cancer and HPV Research (8 papers). Athina Giannoudis is often cited by papers focused on Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Cervical Cancer and HPV Research (8 papers). Athina Giannoudis collaborates with scholars based in United Kingdom, Greece and United States. Athina Giannoudis's co-authors include Claire E. Lewis, Craig Murdoch, C. Simon Herrington, Munir Pirmohamed, Claire Lucas, R E Clark, Robert J. Harris, Richard E. Clark, Andrea Davies and B. F. Burke and has published in prestigious journals such as Blood, Cancer and Cancer Research.

In The Last Decade

Athina Giannoudis

50 papers receiving 2.6k citations

Hit Papers

Mechanisms regulating the recruitment of macrophages into... 2004 2026 2011 2018 2004 200 400 600

Peers

Athina Giannoudis
Elizabeth Hyjek United States
Dianne Sako United States
Kevin T. McDonagh United States
Niels Bovenschen Netherlands
Erlinda M. Gordon United States
Elizabeth Hyjek United States
Athina Giannoudis
Citations per year, relative to Athina Giannoudis Athina Giannoudis (= 1×) peers Elizabeth Hyjek

Countries citing papers authored by Athina Giannoudis

Since Specialization
Citations

This map shows the geographic impact of Athina Giannoudis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athina Giannoudis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athina Giannoudis more than expected).

Fields of papers citing papers by Athina Giannoudis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athina Giannoudis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athina Giannoudis. The network helps show where Athina Giannoudis may publish in the future.

Co-authorship network of co-authors of Athina Giannoudis

This figure shows the co-authorship network connecting the top 25 collaborators of Athina Giannoudis. A scholar is included among the top collaborators of Athina Giannoudis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athina Giannoudis. Athina Giannoudis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giannoudis, Athina, et al.. (2025). The Presence of Non-Exhausted Senescent T Cells in Breast Cancer Patients. Asian Pacific Journal of Cancer Prevention. 26(5). 1633–1640. 1 indexed citations
2.
Giannoudis, Athina, Ethan Sokol, Evangelia Razis, et al.. (2024). Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitors. npj Precision Oncology. 8(1). 282–282. 4 indexed citations
3.
Giannoudis, Athina, et al.. (2024). ENO1 as a Biomarker of Breast Cancer Progression and Metastasis: A Bioinformatic Approach Using Available Databases. Breast Cancer Basic and Clinical Research. 18. 782024208–782024208. 3 indexed citations
5.
Giannoudis, Athina, Ethan Sokol, Shakti Ramkissoon, et al.. (2023). Abstract P5-14-10: Targetable alterations and genomic signatures within breast cancer brain metastases: Data from comprehensive genomic profiling of 761 breast cancer brain metastases. Cancer Research. 83(5_Supplement). P5–14. 1 indexed citations
6.
Das, Mitali, Athina Giannoudis, & Vijay Sharma. (2022). The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approach. Scientific Reports. 12(1). 16441–16441. 19 indexed citations
7.
Giannoudis, Athina, Alexander Sartori, Rasheed Zakaria, et al.. (2021). Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survival. Breast Cancer Research and Treatment. 190(2). 241–253. 10 indexed citations
8.
Giannoudis, Athina, et al.. (2020). The genomic landscape of breast cancer brain metastases: a systematic review. The Lancet Oncology. 22(1). e7–e17. 72 indexed citations
9.
Redaelli, Sara, Pietro Perini, Monica Ceccon, et al.. (2015). In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib. Journal of Hematology & Oncology. 8(1). 81–81. 18 indexed citations
10.
Lucas, Claire, R. J. C. Harris, Athina Giannoudis, Elizabeth S. McDonald, & R E Clark. (2014). Low leukotriene B4 receptor 1 leads to ALOX5 downregulation at diagnosis of chronic myeloid leukemia. Haematologica. 99(11). 1710–1715. 13 indexed citations
11.
Wang, Lihui, et al.. (2012). Peroxisome proliferator–activated receptor activation increases imatinib uptake and killing of chronic myeloid leukemia cells. Experimental Hematology. 40(10). 811–819.e2. 15 indexed citations
12.
Muthana, Munitta, Athina Giannoudis, Simon D. Scott, et al.. (2011). Use of Macrophages to Target Therapeutic Adenovirus to Human Prostate Tumors. Cancer Research. 71(5). 1805–1815. 101 indexed citations
13.
Dickens, David, Andrew Owen, Ana Alfirevic, et al.. (2011). Lamotrigine is a substrate for OCT1 in brain endothelial cells. Biochemical Pharmacology. 83(6). 805–814. 70 indexed citations
14.
Clark, Richard E., Andrea Davies, Munir Pirmohamed, & Athina Giannoudis. (2008). Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemia. Leukemia & lymphoma. 49(4). 639–642. 17 indexed citations
15.
Mammas, Ioannis, George Sourvinos, Athina Giannoudis, & Demetrios�� Spandidos. (2008). Human Papilloma Virus (HPV) and Host Cellular Interactions. Pathology & Oncology Research. 14(4). 345–354. 42 indexed citations
16.
Wang, L, Athina Giannoudis, Steven Lane, et al.. (2007). Expression of the Uptake Drug Transporter hOCT1 is an Important Clinical Determinant of the Response to Imatinib in Chronic Myeloid Leukemia. Clinical Pharmacology & Therapeutics. 83(2). 258–264. 207 indexed citations
17.
Burke, B. F., Athina Giannoudis, Kevin P. Corke, et al.. (2003). Hypoxia-Induced Gene Expression in Human Macrophages. American Journal Of Pathology. 163(4). 1233–1243. 221 indexed citations
18.
Giannoudis, Athina, Mark van Duin, Peter J.F. Snijders, & C. Simon Herrington. (2001). Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix. British Journal of Cancer. 84(8). 1058–1063. 27 indexed citations
19.
Giannoudis, Athina, M F Evans, S A Southern, & C. Simon Herrington. (2000). Basal keratinocyte tetrasomy in low-grade squamous intra-epithelial lesions of the cervix is restricted to high and intermediate risk HPV infection but is not type-specific. British Journal of Cancer. 82(2). 424–428. 26 indexed citations
20.
Giannoudis, Athina, D. A. Graham, S A Southern, & C. Simon Herrington. (1999). p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix. International Journal of Cancer. 83(1). 66–69. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026